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Dedication ((optional)) 
Abstract: During an investigation into the potential union of Lewis 
basic isothiourea organocatalysis and gold catalysis, the formation of 
gold-isothiourea complexes was observed. These novel gold 
complexes were formed in high yield and were found to be air- and 
moisture stable. A series of neutral and cationic chiral gold(I) and 
gold(III) complexes bearing enantiopure isothiourea ligands was 
therefore synthesized and fully characterized. The steric and 
electronic properties of the isothiourea ligands was assessed 
through calculation of their percent buried volume and the synthesis 
and analysis of novel iridium(I)-isothiourea carbonyl complexes. The 
novel gold(I)- and gold(III)-isothiourea complexes have been applied 
in preliminary catalytic and biological studies, and display promising 
preliminary levels of catalytic activity and potency towards cancerous 
cell lines and clinically-relevant enzymes. 
1. Introduction 
The concept of combining transition metal catalysis and 
organocatalysis is attractive due to the potential for achieving 
novel transformations impossible with either catalytic system 
alone.[1] This approach offers many advantages, in particular for 
the development of enantioselective transformations, where an 
appropriate combination of chiral catalysts can be used to 
achieve unprecedented levels of stereocontrol. Despite this 
great promise, a number of significant challenges exist. The 
reaction conditions must be compatible with both catalytic 
manifolds and each catalyst must be able to selectively activate 
a specific substrate and/or intermediate. Most significantly, the 
two catalysts must not engage exclusively in an interaction that 
inhibits one or both of the catalytic manifolds. This is a particular 
concern when combining a Lewis acidic transition metal and a 
Lewis basic organocatalyst. 
Based on the collective expertise of our research groups, we 
envisaged the combination of isothiourea organocatalysis and 
gold catalysis may be productive for the development of novel 
enantioselective transformations.[2,3] Chiral isothioureas have 
been widely-applied as Lewis base organocatalysts, capable of 
promoting a diverse set of enantioselective transformations via 
acyl isothiouronium, isothiouronium enolate and α,β-unsaturated 
acyl isothiouronium intermediates.[2] Key to effective enantio-
induction in these processes is the proximity of an sp3-
hydribrized stereogenic carbon adjacent to the catalytically-
active Lewis basic sp2-hybridized nitrogen (Figure 1).[4] 
 
Figure 1. Selected achiral and chiral Lewis basic isothiourea organocatalysts. 
Recent developments in isothiourea catalysis have focused on 
combining the nucleophilic isothiouronium enolate intermediate 
with an electrophile that is catalytically-generated by a transition 
metal (Scheme 1a).[5] Snaddon was first to report this successful 
union by using a combination of BTM 2 and a palladium catalyst 
for the enantioselective -allylation of aryl acetic acid esters 
(Scheme 1b).[5a-f] Shortly afterwards, Hartwig reported a 
complementary iridium-catalyzed method to provide the related 
branched products (Scheme 1c).[5h] Significantly, through 
variation of the enantiomer of the isothiourea and iridium 
catalysts applied, all four stereoisomers of the product could be 
accessed with excellent diastereo- and enantioselectivity. More 
recently, Gong, and Cao and Wu have exploited the merger of 
isothiourea catalysis with copper catalysis, through the 
generation of electrophilic copper-allenylidene intermediates[5i,j] 
(Scheme 1d) or diaziridinone activation.[5k] In each example it 
has been assumed that the Lewis base and transition metal-
catalyzed cycles operate independently, with no direct 
interaction between the Lewis basic isothiourea and transition 
metal required. 
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Scheme 1. Recent examples of combining isothiourea and transition metal 
catalysis. 
We reasoned that the ability of gold catalysts to activate alkenes 
and alkynes could be exploited through combination with 
isothiourea catalysis for the enantioselective -alkylation and -
vinylation of esters. The combination of gold with primary and 
secondary amine catalysts has previously been explored,[6,7] but 
to the best of our knowledge the use of tertiary amine catalysts 
has not been reported. Initial studies into the potential of this 
dual catalytic manifold found that despite screening a range of 
gold complexes, solvents and reaction temperatures, neither 
intra- nor intermolecular processes were successful (Scheme 
2).[8] In each case only starting materials or hydrolysis products 
were observed. Control studies identified rapid and irreversible 
binding between the Lewis basic isothiourea and the Lewis 
acidic gold catalyst. In contrast to previous methods using 
primary and secondary amines, the addition of acid could not be 
used to circumvent this deactivation pathway due to the 
necessity of basic conditions for successful isothiouronium 
enolate formation.  
 
Scheme 2. Initial studies into the union of isothiourea and gold catalysis. 
A survey of the literature at this point revealed that although gold 
complexes containing simple alkylamine, nitrile, imine and 
pyridine ligands have been explored,[9,10] the use of other neutral 
sp2-hybridized nitrogen-based ligands has been less thoroughly 
investigated. Schmidbaur and Cronje have reported the 
synthesis and characterization of neutral and cationic gold(I)-
guanidine and isothiourea complexes 3 and 4 (Figure 2);[11,12] 
however, these studies were mostly limited to the solution and 
solid-state behavior of the complexes. Cronje also applied these 
novel gold complexes in antitumoral and antimalarial screening, 
however only minimal activity was observed.[12] Even more 
scarce are reports on the synthesis of gold complexes bearing 
chiral sp2-hybridized nitrogen-based ligands. Peters synthesized 
and characterized dinuclear gold(I) and gold(II) ferrocenyl 
oxazoline complexes 6,[13] however no applications of these 
novel chiral complexes were disclosed. 
 
Figure 2. Cationic and neutral gold(I)-guanidine and chiral dinuclear gold(I)-
oxazoline complexes. 
Due to the wide variety of applications of gold complexes,[1,14] 
where the nature of the ligands are pivotal for imparting stability 
and functionality,[15] we pursued the synthesis of gold complexes 
bearing novel isothiourea ligands. Beyond gold chemistry, the 
use of isothiourea ligands for transition metal catalysts in 
general has been somewhat overlooked. An example from 
Doyle has demonstrated the addition of a chiral isothiourea to 
the cobalt-catalyzed hydrofluorination of epoxides has a positive 
effect.[16] It was proposed, based on spectroscopic studies, that 
the isothiourea acts as a ligand to facilitate complex dimer 
dissociation and enhance reactivity, however no isolated 
complexes were reported. Considering this precedent, and the 
current interest in combining isothiourea- and transition metal 
catalysis, we believed that a fundamental study on the potential 
for isothioureas to act as ligands for transition metals would be 
of significant interest. Herein we report the synthesis, 
characterization and preliminary applications of a range of novel 
cationic and neutral chiral gold(I) and gold(III) isothiourea 
complexes. The inherent steric and electronic properties of the 
isothiourea ligands are assessed through computation and the 
synthesis of novel iridium(I) isothiourea complexes, and their 
catalytic and biological activities are evaluated in some 
preliminary studies. 
2. Results and Discussion 
2.1. Cationic Heteroleptic Gold(I)-Isothiourea Complexes 
2.1.1. Synthesis 
The synthesis of cationic heteroleptic gold(I)-isothiourea 
complexes was explored using easily-accessed gold(I) chloride 
NHC and phosphine precursors. Halide abstraction from either 
[Au(IPr)(Cl)] (IPr = N,N'-bis(2,6-diisopropylphenyl)imidazol-2-
ylidene) 7 or [Au(PPh3)(Cl)] 8 using AgNTf2 or AgBF4, followed 
by addition of an isothiourea led to rapid and quantitative 
conversion to new gold(I)-isothiourea complexes 9–12 (Scheme 
3). Recrystallization of the crude products from pentane afforded 
pure, air- and moisture-stable microcrystalline gold(I) complexes. 
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Using this simple synthetic approach, a series of cationic gold(I) 
complexes containing triflimide or tetrafluoroborate counterions 
were synthesized in excellent yield (82–99%). 
 
Scheme 3. Synthesis of cationic heteroleptic gold(I)-isothiourea complexes 
from gold(I) chloride precursors using silver-mediated halide abstraction. IPr = 
N,N'-bis(2,6-diisopropylphenyl)imidazol-2-ylidene. 
Due to the commonly-observed non-innocent role of silver in 
gold catalysis,[17] alternative methods for the synthesis of these 
complexes was investigated. We recently reported the silver-free 
preparation of gold(I)(NHC)(acetonyl) complexes from 
[Au(SMe2)(Cl)], an NHC·HCl salt and acetone in the presence of 
potassium carbonate.[18] These gold(I)(NHC)(acetonyl) 
complexes proved excellent precursors to a range of gold 
complexes. Applying this approach to the current study, 
activation of [Au(IPr)(CH2C(O)CH3)] 13 using HBF4·OEt2, 
followed by the addition of isothiourea (2S,3R)-3 gave (2S,3R)-
9·BF4 in quantitative yield (Scheme 4). 
 
Scheme 4. Synthesis of cationic heteroleptic gold(I) complex (2S,3R)-9·BF4 
from Au(I)-acetonyl complex 13. 
The isolated Gagosz-type complexes 14 and 15,[19] which 
contain a labile inner-sphere triflimide ligand, can also be 
synthesized from gold(I)(NHC)(acetonyl) complexes.[18a] 
Reaction of these gold(I) triflimide complexes with isothioureas 
(2S,3R)-3, (2R,3S)-3, (S)-2 or (R)-2 provided cationic gold(I)-
isothiourea complexes in uniformly excellent yields (96–99%) 
(Scheme 5). Using this synthetic approach, the formation of (S)-
17·NTf2 and (2S,3R)-18·NTf2 bearing a chlorinated NHC ligand 
could also be obtained in excellent yield. As a final alternative 
approach, the heteroleptic cationic gold(I) acetonitrile complex, 
[Au(IPr)(NCCH3)][BF4] 16,[20] was applied for the synthesis of 
gold(I)-isothiourea BF4 adducts, (2S,3R)-9·BF4 and (S)-10·BF4, 
which were both obtained in quantitative yield (Scheme 5). 
 
Scheme 5. Synthesis of cationic heteroleptic gold(I)-isothiourea complexes 
from gold(I) triflimide complexes 14 and 15 and gold(I) acetonitrile BF4 adduct 
16. 
2.1.2. Characterization 
Several distinguishing features of the cationic heteroleptic 
gold(I)-isothiourea complexes were observed by 1H and 13C{1H} 
NMR spectroscopy in CDCl3 (Table 1).[21] The C(2) proton of 
HyperBTM 3 (N1-CHPh) was observed to undergo a significant 
upfield shift (H ≈ −0.65 ppm) upon coordination to the NHC-
Au+ fragments of heteroleptic complexes 9 and 17 (entries 1–3). 
In contrast, for [Au(PPh3)(HyperBTM)][NTf2] 11 the C(2) proton 
of HyperBTM appeared in a more deshielded environment (H 
= +0.20 ppm) (entry 4). The same trends were observed for the 
analogous gold(I)-BTM complexes (entries 6–8), with the C(2) 
proton of BTM 2 shielded when in combination with an NHC 
ligand (H ≈ −0.30 ppm); and deshielded when combined with 
PPh3 (H = +0.34 ppm). These variations in the effective 
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Table 1. Selected spectroscopic characterization of cationic heteroleptic gold(I) isothiourea complexes  
entry Compound H(N−CHPh) (ppm) C(N=C−N) (ppm) C(carbenic) (ppm) (N=C−N) (cm−1) 
1 HyperBTM 3 4.93 158.5 - 1627 
2 [Au(IPr)(HyperBTM)][NTf2] 9 4.31 (−0.62)[a] 167.9 (+9.4)[a] 170.6 1578 (−49)[a] 
3 [Au(IPrCl)(HyperBTM)][NTf2] 17 4.27 (−0.66)[a] 168.1 (+9.6)[a] 170.7 1576 (−51)[a] 
4 [Au(PPh3)(HyperBTM)][NTf2] 11 5.13 (+0.20)[a] 166.8 (+8.3)[a] - 1570 (−57)[a] 
5 BTM 2 5.67 166.6 - 1593 
6 [Au(IPr)(BTM)][NTf2] 10 5.36 (−0.31)[b] 172.2 (+5.6)[b] 171.7 1560 (−33)[b] 
7 [Au(IPrCl)(BTM)][NTf2] 18 5.37 (−0.30)[b] 172.4 (+5.8)[b] 171.8 1565 (−28)[b] 
8 [Au(PPh3)(BTM)][NTf2] 12 6.01 (+0.34)[b] 171.6 (+5.0)[b] - 1570 (−23)[b] 
[a] value in parentheses relative to free HyperBTM 3. [b] value in parentheses relative to free BTM 2. 
shielding of the C(2) proton of the isothiourea ligand may reflect 
differences in ion pairing between the heteroleptic complex and 
the triflimide counterion influenced by the nature of the ancillary 
ligand.[22] Another interesting feature observed by 1H NMR 
spectroscopy was that the CH signals of the iso-propyl groups of 
the NHC ligands in [Au(IPr)(HyperBTM)][NTf2] 9 and 
[Au(IPrCl)(HyperBTM)][NTf2] 17 appear as two sets of septets 
centred at ~2.35 ppm. This is consistent with a non-symmetrical 
environment around the gold centre and indicate that rotation 
around the Au–N is slow on the NMR timescale. 
Analysis by 13C{1H} NMR spectroscopy revealed that the central 
isothiouronium carbon (N=C–N) was shifted downfield in all 
complexes, relative to the parent isothiourea (C = +5–10 ppm). 
The magnitude of this downfield shift is consistent with those 
previously reported for gold(I)-isothiourea complexes,[12] and 
indicates that the positive charge is delocalized into the 
isothiourea ligand, and at least partially centralized on the 
isothiouronium carbon. The carbenic carbons of the NHC-Au-
isothiourea complexes 9, 10, 17, and 18 were observed at 171–
172 ppm (Table 1, entries 2,3,6,7). These carbenic carbon 
chemical shifts are downfield relative to analogous cationic 
homoleptic and heteroleptic gold(I)-NHC complexes bearing 
ancillary NHC and phosphine ligands {e.g. [Au(IPr)2][BF4]: C = 
184.2 ppm; [Au(IPr)(PPh3)][BF4]:C = 188.2 ppm},[23] but upfield 
relative to cationic heteroleptic complexes bearing other neutral 
nitrogen-based ligands {e.g. [Au(IPr)(NCMe)][BF4]: C = 165.9 
ppm; [Au(IPr)(pyridine)][PF6]: C = 167.1 ppm; 
[Au(NHC)(ylideneamine)][NO3]:C = 165.6 ppm}.[9f,12] This 
suggests that the gold centres in the heteroleptic complexes 
bearing isothiourea ligands are more Lewis acidic than the 
homoleptic and heteroleptic gold(I)-NHC complexes bearing 
ancillary NHC and phosphine ligands; but less Lewis acidic than 
those bearing alternative nitrogen-based ligands. This latter 
observation could be rationalized by the high Lewis basicity of 
isothioureas translating to their efficacy as σ-donating ligands. 
Infrared spectroscopic analysis of the cationic heteroleptic 
complexes revealed a lower stretching frequency of the N=C–N 
unit in all complexes relative to the free isothiourea (Table 1). 
This effect was most pronounced for complexes containing 
HyperBTM (entries 1–4,  = −49−57 cm−1). This indicates that 
the C=N bond of the isothiouronium is weakened upon 
complexation, and could be consistent with an increased 
contribution from resonance bonding structures within the 
isothiourea ligand. The complexes did not exhibit any 
luminescence and therefore their photophysical properties were 
not assessed further. 
The structure of the heteroleptic complex (2R,3S)-9·NTf2 was 
unambiguously established by single crystal X-ray diffraction 
analysis (Figure 3).[24] The isothiourea binds as expected 
through the nitrogen atom, with the complex adopting a near 
linear geometry, with an N−Au−C angle of 176.2(5)°. The length 
of the Au−N bond (2.053(11) Å) is slightly longer than those 
reported for heteroleptic ylideneamine and acetonitrile 
complexes ( = 0.02–0.04 Å),[12,9f,20] but similar in length to 
heteroleptic tetramethylguanidine and pyridine complexes.[11,9f] 
The Au−C distance of 1.979(13) Å is similar to that found in 
heteroleptic gold(I)-NHC complexes bearing pyridine and 
acetonitrile ligands, but shorter than in cationic homoleptic and 
heteroleptic gold(I)-NHC complexes bearing ancillary NHC and 
phosphine ligands. The N31−C32 and C32−N40 distances of 
1.288(16) and 1.367(18) Å within the isothiourea ligand, reveal a 
slight extension of the N31−C32 bond (+0.01 Å) and contraction 
of the C32−N40 bond (−0.02 Å) relative to the free isothiourea. 
This increase in N31−C32 bond length upon complexation is 
consistent with the observed reduction in IR stretching frequency 
of this fragment. 
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(2R,3S)-9·NTf2 
Au–N31 Au–C1 N31–C32 C32–N40 N31–Au–C1 
2.053(11) Å 1.979(13) Å 1.288(16) Å 1.367(18) Å 176.2(5)° 
Figure 3. Thermal ellipsoid representation of (2R,3S)-9·NTf2 at 50% 
probability. Hydrogen atoms omitted for clarity. Selected distances (Å) and 
angles (°) given. 
2.2. Neutral Gold(I)-Isothiourea Complexes 
2.2.1. Synthesis 
The synthesis of neutral gold(I)-isothiourea chloride complexes 
was next targeted. Mixing [Au(SMe2)(Cl)] 19 and (S)-BTM (S)-2 
in THF resulted in no conversion after 3 days at r.t.; however, 
upon heating the same reaction mixture at 60 °C [Au((S)-
BTM)(Cl)] (S)-21 was obtained in quantitative yield within 1 h 
(Scheme 6). The method was also applied to the synthesis of 
gold(I) complexes bearing the (R)-enantiomer of BTM (R)-2; 
racemic and both enantiomers of HyperBTM 3; and the achiral 
isothiourea DHPB 1. The neutral gold(I) complexes bearing BTM 
and HyperBTM ligands, 21 and 20, were obtained in quantitative 
yield, while complex 22, bearing the achiral DHPB ligand, was 
obtained in 85% yield. For the synthesis of 22 the use of K2CO3, 
and an extended reaction time of 16 h, was required to obtain 
high yields. All six complexes were obtained as bench-stable 
solids. This is in contrast to previously-reported gold(I)-guanidine 
chloride and bromide complexes, which were observed to 
undergo rapid decomposition to give gold metal within a few 
hours.[11] 
2.2.2. Characterization 
1H Spectroscopic analysis of the neutral gold(I)-isothiourea 
complexes revealed the C(2) proton of all isothiourea ligands 
had undergone a small downfield shift relative to the 
corresponding free isothiourea (Scheme 6, H = +0.06–0.18 
ppm). A much more significant effect was observed by 13C{1H} 
NMR spectroscopy, with substantial upfield shifts observed for 
the isothiouronium carbons (N=C–N) relative to the free 
isothioureas (C = −18–27 ppm). The IR stretching frequencies 
 
H (N−CHPh) (ppm) 5.09 (+0.18)[b]  5.73 (+0.06)[c]  3.90 (+0.11)[d]  
C (N=C−N) (ppm) 140.6 (−17.9)[b]  140.0 (−26.6)[c]  nd (−)[e]  
 (N=C−N) (cm−1) 1575 (−52)[b]  1564 (−29)[c]  1580 (−36)[d]  
Scheme 6. Synthesis and selected spectroscopic characterization of neutral 
gold(I)-isothiourea chloride complexes 20–22. [a] 16 h reaction time. [b] value 
in parentheses relative to free HyperBTM 3. [c] value in parentheses relative to 
free BTM 2. [d] value in parentheses relative to free DHPB 1. [e] not 
determined. 
of the isothiouronium units (N=C–N) were reduced in all 
complexes relative to the free isothiourea ( = −39−52 cm−1). 
This trend is consistent with that observed for the cationic 
heteroleptic series, and may indicate increased contribution from 
resonance bonding structures within the isothiourea ligand. It 
may be pertinent to note that this apparent increased 
delocalization in bonding does not necessarily correlate with an 
increase in positive charge on the isothiourea ligand, as 
evidenced by the shielding (rather than deshielding) of the 
isothiouronium carbon. Once again, the complexes did not 
exhibit luminescence and therefore their photophysical 
properties were not assessed. 
Colourless crystals of (2R,3S)-20, (±)-20, (S)-21 and 22 were 
grown by slow diffusion of pentane or hexane into saturated 
solutions in CH2Cl2, and their structures were unambiguously 
determined by single crystal X-ray diffraction analysis (Figure 
4).[25] All complexes are virtually linear along the N1–Au–
N31/N1–Au–Cl axes (177.3–179.5°), with Au–N bond lengths 
within the range of 2.003–2.021 Å. These Au–N bond lengths 
are considerably shorter than that observed for the heteroleptic 
complex (2R,3S)-9·NTf2 (2.053 Å). 
In complexes (2R,3S)-20 and (±)-20 bearing the HyperBTM 
ligand, distortions in the nitrogen-carbon bond lengths were 
consistent with the data obtained for the heteroleptic complex 
(2R,3S)-9·NTf2. In both cases, slight extension of the 
N1−C2/N31−C32 bond (+0.013 Å on average) and contraction of 
the C2−N10/C32−N40 bond (−0.03 Å on average) relative to the 
free isothiourea was observed. The enhanced extension of the 
N1−C2/N31−C32 bond, relative to that observed for the 
heteroleptic complex (2R,3S)-9·NTf2, is consistent with the lower 
stretching frequency of the N=C−N fragment observed by IR 
spectroscopy. 
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 (2R,3S)-20  (±)-20 
Au–N1 2.011(8) Å  2.003(5) Å 
Au–N31 2.006(8) Å  2.010(5) Å 
N1–C2 1.297(14) Å  1.280(6) Å 
N31–C32 1.288(14) Å  1.301(7) Å 
C2–N10 1.358(13) Å  1.358(8) Å 
C32–N40 1.355(13) Å  1.349(8) Å 
N1–Au–N31 177.3(4)°  178.69(15)° 
 
  
 (S)-21  22 
Au–N1 2.016(16) Å  2.021(9) Å 
N1–C2 1.31(2) Å  1.316(15) Å 
C2–N10 1.34(2) Å  1.341(13) Å 
Au–Cl 2.248(5) Å  2.255(3) Å 
N1–Au–Cl 179.5(4)°  178.7(3)° 
Figure 4. Thermal ellipsoid representations of (2R,3S)-20, (±)-20, (S)-21 and 
22 at 50% probability. Hydrogen atoms omitted for clarity. Selected distances 
(Å) and angles (°) given.  
The X-ray crystal structures of the neutral gold(I)-isothiourea 
complexes also reveal some striking differences. Whilst (S)-21 
and 22 crystallize as linear gold(I)-isothiourea chloride 
complexes, (2R,3S)-20 and (±)-20 crystallize in a cation-anion 
arrangement, consisting of a cationic homoleptic gold(I)-
diisothiourea component and an anionic gold(I)-dichloride 
counterion.[11] An interesting feature of the homoleptic 
enantiopure complex (2R,3S)-20 is that the isothiourea ligands 
are arranged in a head-to-tail configuration, whilst the racemic 
version (±)-20 crystallizes in a heterochiral head-to-head 
arrangement. In both cases, the isothiourea ligands are 
effectively co-planar with one another. It is worth noting that all 
four complexes appear similar by NMR spectroscopic analysis, 
with only a single species observed in each case. This indicates 
that the solid state structures may not be an accurate 
representation of the complexes in the solution phase, and have 
therefore been simply represented as gold(I)-isothiourea 
chloride complexes in Scheme 6. 
2.3. Gold(III)-Isothiourea Complexes 
2.3.1. Synthesis 
Having prepared and characterized a range of neutral and 
cationic gold(I)-isothiourea complexes, the synthesis of gold(III)-
isothiourea analogues was investigated.[10j,26] The attempted 
oxidation of (2S,3R)-20 and (S)-21 using Br2 or PhI(OAc)2 
resulted in the formation of several species which could not be 
fully analyzed or isolated. In contrast, the use of 1.2 equiv. of 
PhICl2 led to the corresponding gold(III)-isothiourea trichloride 
complexes (2S,3R)-23 and (S)-24 as purple and magenta solids 
in quantitative yield (Scheme 7). Notably, oxidation of sulfur in 
either isothiourea ligand, or the oxidative aromatization of BTM 2 
was not observed. The same method was successfully applied 
to the opposite enantiomers of 20 and 21, however the 
attempted oxidation of 22 led to a complex mixture of products. 
In addition, oxidation of the cationic heteroleptic complex (S)-
10·NTf2 gave a complex mixture of gold(I) and gold(III) species, 
with [Au(IPr)Cl3] identified as the major product.[26b] To the best 
of our knowledge, these complexes represent the first gold(III) 
complexes bearing chiral nitrogen-based ligands. 
 
H (N−CHPh) (ppm) 5.32 (+0.39)[a] 6.36 (+0.69)[b] 
C (N=C−N) (ppm) 165.1 (+6.6)[a] 169.7 (+3.1)[b] 
 (N=C−N) (cm−1) 1574 (−53)[a] 1560 (−33)[b] 
Scheme 7. Synthesis and selected spectroscopic characterization of gold(III)-
isothiourea trichloride complexes. [a] value in parentheses relative to free 
HyperBTM 4. [b] value in parentheses relative to free BTM 5. 
2.3.2. Characterization 
1H Spectroscopic analysis of the gold(III)-isothiourea trichloride 
complexes 23 and 24 revealed that the C(2) proton of both 
isothiourea ligands had undergone a large downfield shift 
relative to the corresponding free isothiourea (Scheme 7, H = 
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+0.39–0.69 ppm). This downfield shift was significantly 
enhanced relative to that observed for the corresponding gold(I) 
chloride complexes 20 and 21, and is consistent with the 
increased Lewis acidity of the d8 gold(III) centre. In both 
complexes there is also a similar substantial downfield shift for 
the isothiouronium carbons (N=C–N) relative to the gold(I) 
chloride complexes (C = +25-30 ppm) (cf. Scheme 6). The IR 
stretching frequencies of the isothiouronium units (N=C–N) were 
also reduced in both complexes relative to the free isothiourea 
( = −33−53 cm−1), and to a similar extent to that observed for 
the corresponding neutral and cationic gold(I) complexes. Once 
again, the complexes did not exhibit any luminescence and 
therefore their photophysical properties were not assessed. 
Colourless crystals of (2R,3S)-23 and (S)-24 were grown by 
slow diffusion of pentane or hexane into saturated solutions in 
CH2Cl2, and their structures were unambiguously determined by 
single crystal X-ray diffraction analysis (Figure 5).[27] (2R,3S)-23 
crystallized in the expected square planar configuration, in which 
the Clcis–Au–Clcis plane was close to perpendicular to the plane 
of the isothiourea ligand (77.1°). Extension of the N1−C2 
bond(+0.015 Å) and contraction of the C2−N10 bond (−0.045 Å),   
 
  
 (2R,3S)-23  (S)-24 
Au–N1 2.022(5) Å  1.988(11) Å 
Au–N21 -  1.992(10) Å 
N1–C2 1.294(7) Å  1.323(18) Å 
N21–C22 -  1.306(18) Å 
C2–N10 1.341(8) Å  1.321(18) Å 
C22–N30 -  1.310(17) Å 
Au–Cltrans 2.264(2) Å  - 
Au–Clcis 2.276 Å[a]  2.275 Å[a] 
N1–Au–
Cl3/N21 
179.20(15)°  177.5(4)° 
N1–Au–Clcis 87.73(15)/90.68(15)°  89.2(3)/92.5(3)° 
Figure 5. Thermal ellipsoid representations of (2R,3S)-23 and (S)-24 at 50% 
probability. Hydrogen atoms omitted for clarity. Selected distances (Å) and 
angles (°) given. [a] Average value given. 
relative to the free isothiourea, was consistent with the trend 
observed for the heteroleptic and neutral gold(I) complexes, and 
with the reduction in stretching frequency of the N=C−N 
fragment observed by IR spectroscopy. In contrast, (S)-24 
crystallized in a cation-anion arrangement, similar to those 
observed for (2R,3S)-20 and (±)-20. In this case however, the 
cationic gold(III) diisothiourea dichloride complex and [AuCl4]− 
counterion exist as a loose ion pair with no close Au−Au 
contacts. As before, it is possible that the solid state structure 
may not necessarily reflect the arrangement in solution. 
2.4. Steric and Electronic Properties of Isothiourea Ligands 
To provide an improved fundamental understanding of 
isothiourea ligands in transition metal complexes, we next 
appraised the steric and electronic parameters of the novel 
isothiourea ligands used in this study. The steric properties of 
the three isothiourea ligands was first investigated using the 
percent buried volume (%VBur) metric.[28] Modelling the neutral 
gold(I) complexes synthesized in this study, we obtained %VBur 
values of 28.7% for (2R,3S)-20; 27.5% for (S)-21; and 25.1% for 
22.[8] These steric parameters suggest that the isothiourea 
ligands are quite small, with these %VBur values coinciding with 
the lower range of %VBur values reported for common carbene 
ligands (%VBur = 26–51%), and below the range reported for 
phosphines (%VBur = 38–64%).[28]  
The electronic effect of the isothiourea ligands was assessed 
using the Tolman Electronic Parameter (TEP).[29] To determine 
this parameter, the synthesis of iridium(I)-isothiourea carbonyl 
complexes was undertaken. The reaction of [IrCl(cod)]2 25 with 
either (2S,3R)-HyperBTM (2S,3R)-4 or DHPB 6 gave mono-
coordinated [IrCl{(2S,3R)-HyperBTM}(cod)] (2S,3R)-26 and 
[IrCl(DHPB)(cod)] 27 as yellow solids in good to excellent 
yield.[30] In contrast, the reaction of [IrCl(cod)]2 25 with BTM 5 led 
to a complex inseparable mixture of products. Reaction of the 
iridium(I) isothiourea complexes (2S,3R)-26 and 27 with 1 atm of 
carbon monoxide gave [IrCl{(2S,3R)-HyperBTM}(CO)2] (2S,3R)-
28 and [IrCl(DHPB)(CO)2] 29 as off-white solids in quantitative 
yield. (2S,3R)-26 and 27 and their carbonylated analogues, 
(2S,3R)-28 and 29, were all produced as air- and bench-stable 
complexes. It is interesting to note that in the methodology 
reported by Hartwig on the union of isothiourea and iridium 
catalysis, a pre-formed iridium phosphoramidite complex was 
used.[5h] When in situ formation of the complex from [IrCl(cod)]2 
25 and free ligand in the presence of the isothiourea catalyst 
was attempted, only minimal product formation was achieved. 
This result may be consistent with the effective binding we have 
observed between isothioureas and iridium(I).  
IR spectroscopic analysis was used to obtain the CO stretching 
frequencies [(CO)] for the iridium(I)-isothiourea complexes, 
(2S,3R)-28 and 29 (Scheme 8). Two variations of a linear 
regression equation have been reported for the calculation of 
TEPs of phosphine and NHC ligands bound to Ir(L)(Cl)(CO)2 
complexes by Crabtree[31a] and Nolan,[31b] respectively. Applying 
these two methods to the isothiourea ligands reported in this 
study provide values of 2052.4 and 2048.1 cm−1 for HyperBTM 4, 
and 2044.1 and 2038.3 cm−1 for DHPB 6. This analysis suggests 
that these isothiourea ligands are significantly more electron-
donating than phosphine ligands (TEP of PCy3 = 2056.4 cm−1; 
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PPh3 = 2068.9 cm−1) and similarly or more electron-donating 
than NHC ligands (TEP of IAd = 2049.5 cm−1; IPr = 2051.5 cm−1). 
This indicates that the isothiourea ligands used in this study are 
highly efficient -donor ligands. 
 
(CO) (cm−1) 1980.9; 2061.9  1967.4; 2052.3 
(CO)average 
(cm−1)
2021.4  2009.8 
TEP (cm−1)[a] 2052.4  2044.1 
TEP (cm−1)[b] 2048.1  2038.3 
Scheme 8. Synthesis and characterization of iridium(I) isothiourea complexes. 
[a] calculated using TEP = 0.722 × (CO)average + 593 cm−1.[31a] [b] calculated 
using TEP = 0.847 × (CO)average + 336 cm−1.[31b]  
The structure of (2S,3R)-26 was unambiguously determined by 
single crystal X-ray diffraction analysis (Figure 6).]32] The Ir−N1 
distance of 2.104(8) Å, was longer than those observed for the 
gold(I) and gold(III) complexes (1.99–2.05 Å). The complex 
adopted the expected square planar configuration (N1−Ir−Cl = 
87.0(2)°), with the isothiourea ligand in a perpendicular plane to 
the Ir−Cl bond (C2−N1−Ir−Cl = 91.1(6)°). 
 
(2S,3R)-26 
Ir–N1 N1–C2 C2–N10 N1–Ir–Cl C2–N1–Ir–Cl 
2.104(8) Å 1.257(13) Å 1.365(13) Å 87.0(2)° 91.1(6)° 
Figure 6. Thermal ellipsoid representation of (2S,3R)-26 at 50% probability. 
Hydrogens omitted for clarity. Selected distances (Å) and angles (°) given. 
2.5. Preliminary Catalytic and Biological Studies 
Having prepared and characterized a range of gold(I) and 
gold(III)-isothiourea complexes, preliminary investigations into 
their catalytic and biological activities were performed.  
2.5.1. Catalytic studies 
Initial studies focused on using heteroleptic gold(I) complexes as 
pre-catalysts for the hydroalkoxylation-Claisen rearrangement 
using diphenylacetylene 30 and allyl alcohol 31 to give 
homoallylic ketone 32.]33] Stoichiometric studies had 
demonstrated that treatment of the heteroleptic gold(I) 
complexes with HBF4·OEt2 would provide [Au(IPr)]+ following 
release of the protonated isothiourea ligand. We speculated that 
the protonated chiral isothiourea may be able to operate as a 
hydrogen bond donor to catalyze the stereo-determining step of 
the transformation. Activation of (2S,3R)-9·NTf2 (0.5 mol%) 
using HBF4·OEt2 (0.5 mol%) provided homoallylic ketone 32 in 
quantitative yield after 5 h at 120 °C, however the product was 
obtained as a racemate (Table 5, entry 1). For context, the state-
of-the-art pre-catalyst, Au(IPrCl)(NTf2), provides 32 in quantitative 
yield after 20 min under analogous conditions.[33] The reaction 
temperature could be reduced to 60 °C using either (2S,3R)-
9·NTf2 or (2S,3R)-11·BF4 as pre-catalyst, providing 32 as a 
racemate in 52–54% yield after 72 h (entries 2,3). In an attempt 
to generate a chiral gold(I) catalyst in situ, activation of the 
neutral gold(I) complex (2S,3R)-20 using sodium tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate (NaBArF4) was investigated, 
however in this case no conversion of the starting materials was 
observed (entry 4). 
Table 2. Gold(I)-catalyzed hydroalkoxylation/Claisen rearrangement of 
diphenylacetylene using allyl alcohol. 
 
entry [Au] Activator (mol%) T (°C) t (h) 32 (%)[a] 
1 (2S,3R)-9·NTf2 HBF4·OEt2 (0.5) 120 5 99 
2 (2S,3R)-9·NTf2 HBF4·OEt2 (0.5) 60 72 52 
3 (2S,3R)-11·BF4 HBF4·OEt2 (0.5) 60 72 54 
4 (2S,3R)-20 NaBArF4 (1) 60 72 0 
Reaction conditions: 30 (0.25 mmol), 31 (0.75 mmol), [Au] (0.5 mol%), 
HBF4·OEt2 (0.5 mol%), solvent-free. [a] Isolated yield.  
The in situ activation of neutral gold(I) pre-catalysts was further 
investigated for the gold-catalyzed cyclization of 
silyloxyenynes.[34] Treatment of (2S,3R)-20 (4 mol%) with NaBF4 
(8 mol%) at either −30 or 0 °C, did not promote cyclization of 
TIPS-protected enol ether 33 (Table 3, entries 1,2), indicating 
significantly lower activity than that previously reported using 
Au(I)diphosphine complexes.[34] Activity was only achieved by 
heating the reaction at reflux, to give cyclopentane 35 in 74% 
yield after 48 h (entry 3). By switching the substrate to TBS-
protected enol ether 34, activation and subsequent cyclization 
could be achieved at −30 °C to give cyclopentane 35 in 17% 
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yield (entry 4), however in both examples the product was 
isolated as a racemate. 
Table 3. Gold(I)-catalyzed cyclization of silyloxyenynes 33 and 34.  
 
entry Substrate NaX T (°C) t (h) 35 (%)[a] 
1 33 NaBF4 −30 16 0 
2 33 NaBF4 0 16 0 
3 33 NaBF4 84 48 76 (74)[b] 
4 34 NaBArF4 −30 16 17[c] 
Reaction conditions: silyloxyenyne 33 or 34 (0.04 mmol), (2S,3R)-20 (4 mol%), 
NaX (8 mol%), DCE (0.02 M). [a] Conversions measured by 1H NMR 
spectroscopy. [b] Isolated yield in parentheses. [c] Major product was 
desilylated starting material. 
Finally, the novel gold(III)-isothiourea complexes, (2S,3R)-23 
and (S)-24, were applied as catalysts for the synthesis of allene 
38 from propargylic alcohol 36 and mesitylene 37 (Table 4).[35] 
Using (S)-24 (4 mol%), activated in situ with AgSbF6 (8 mol%), 
allene 38 was obtained in high conversion after 20 min at 50 °C 
(entry 1). Substituting AgSbF6 with NaBArF4 provided a boost in 
activity, with allene 38 produced in quantitative yield after only 
20 min at room temperature (entry 2). The use of (2S,3R)-23 (4 
mol%), activated in situ with NaBArF4 (8 mol%), proved equally 
effective (entry 3), however in all cases allene 38 was obtained 
as a racemate. The addition of mesitylene 37 to propargylic 
alcohol 36 was completely regioselective using both pre-
catalysts, with no formation of alkyne side-products arising from 
C(1) addition of mesitylene.[35,36] Control reactions demonstrated 
that an activator was required, but that sodium or silver salts 
alone were not catalytically active.[8] 
Table 4. Gold(III)-catalyzed synthesis of allene 38 from propargylic alcohol 36 
and mesitylene 37. 
 
entry [Au] Na or Ag salt T (°C) t (min) 38 (%)[a] 
1 (S)-24 AgSbF6 50 20 83 
2 (S)-24 NaBArF4 r.t. 20 100 
3 (2S,3R)-23 NaBArF4 r.t. 20 100 
Reaction conditions: 36 (0.1 mmol), 37 (0.7 mmol), [Au] (4 mol%), NaBArF4 or 
AgSbF6 (8 mol%), DCE (0.07 M). [a] Conversions determined by 1H NMR 
spectroscopy.  
These preliminary studies have demonstrated a range of 
disparate transformations can be catalyzed by using all three 
classes of the novel gold(I) and gold(III)-isothiourea complexes. 
The isothiourea may either be used as a semi-labile ancillary 
ligand or used as the sole ligand to provide stabilization of the 
active gold catalyst. The isothioureas used in this study are 
representative Lewis basic organocatalysts, and it is therefore 
expected that rational modulation of ligand design will provide 
isothioureas with improved properties as ligands. Such 
modifications could include increasing the size of the 
stereodirecting substituent on the isothiourea, and the 
introduction of a second point of ligation to provide bidentate 
ligand designs. This latter approach could be used for the 
preparation of enantiopure digold complexes,37 or for the 
development of enantioselective Au(III) catalysis.38 Beyond the 
use of Au, complexation of these second generation ligands with 
other transition metals may also provide catalysts, which could 
be applied for a broad range of enantioselective transformations. 
2.5.2. Biological studies 
All three classes of the newly-synthesized cationic and neutral 
gold(I) and gold(III)-isothiourea complexes were next examined 
in some preliminary biological studies.[14a–c,39] Some significant 
results are provided below, with full details available in the 
Supporting Information. 
Screening for antitumoral potency was performed against breast 
cancer cell line MCF-7 and cervical cancer cell line HeLa, with 
cytotoxicity evaluated using mouse fibroblast cell line 3T3 (up to 
30 μM).[8] The most potent complexes were the heteroleptic 
complexes bearing the BTM ligand: (R)-10·BF4, (S)-10·BF4 and 
(S)-12·BF4, with IC50 values down to 0.3±0.01 μm (HeLa) and 
0.6±0.2 μm (MCF-7) obtained. These activities are comparable 
with those reported for the anti-cancer reference drug 
Doxorubicin [IC50 (HeLa) = 0.3±0.02 μM; IC50 (MCF-7) = 
0.92±0.01 μM], however all three complexes were also found to 
be cytotoxic. The most promising compound tested was gold(III) 
complex (S)-24, which displayed significant activity against both 
HeLa and MCF-7 cell lines (IC50 values of 10±1 μM and 11±1 μM, 
respectively), but did not exhibit cytotoxicity. In contrast, the 
enantiomeric gold(III) complex (R)-24 displayed no activity 
against HeLa or MCF-7.  
Inhibition activities towards a range of enzymes including -
glucuronidase,[40] carbonic anhydrase,[41] lipase,[42] 
phosphodiesterase (PDE I),[43] tyrosinase[44] and dipeptidyl 
peptidase were assessed next.[8] All complexes displayed 
exceptionally-high -glucuronidase inhibition, with (S)-12·BF4 
proving the most potent (IC50 = 0.11±0.001 μM). (S)-24, which is 
not cytotoxic, was also a highly potent inhibitor of -
glucuronidase (IC50 = 0.19±0.09 μM) and compares favorably 
with the commercially-available standard inhibitor, D-saccharic 
acid 1,4-lactone (IC50 = 47±2 μM). Inhibition of the other 
enzymes assayed was much less general. Three of the 
heteroleptic gold(I) complexes [(R)-10·BF4, (R)-12·BF4, and (S)-
12·BF4] displayed potent activity against phosphodiesterase 
(PDE I), however all other complexes were inactive. Four of the 
neutral gold(I) complexes [(2R,2S)-20, (2S,2R)-20, (R)-21 and 
(S)-21)] were potent for the inhibition of lipase, but only 
moderate inhibition of carbonic anhydrase, tyrosinase and 
dipeptidyl peptidase was observed with some of the complexes. 
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These preliminary studies demonstrate that gold-isothiourea 
complexes display promising potency against cancer cell lines 
and for the inhibition of enzymes. Further research is currently 
underway to identify the mechanism of action in each example, 
with this information expected to direct further modulation of 
ligand design to provide more active and selective complexes.  
3. Conclusions 
The attempted combination of gold catalysis and isothiouronium 
enolate catalysis resulted in the formation of gold-isothiourea 
complexes. These complexes proved to be air- and moisture-
stable for several months, and therefore their synthesis was 
investigated in more detail. A range of gold(I), gold(III) and 
iridium(I)-isothiourea complexes were synthesized in high yield 
using chiral and achiral isothiourea ligands, with these novel 
complexes characterized both in solution and in the solid state. 
The chiral gold(III)-isothiourea complexes reported here 
represent the first gold(III) species synthesized bearing chiral 
nitrogen-based ligands. The inherent steric and electronic 
properties of the isothiourea ligands have been analyzed using 
the percent buried volume (%VBur) and Tolman Electronic 
Parameter (TEP) descriptors. Based on this analysis, the 
isothioureas used in this study are highly effective σ-donor 
ligands. To the best of our knowledge this is the first appraisal of 
steric and electronic parameters of isothioureas as ligands, and 
thus should provide inspiration for the wider use of related 
ligands for complexation with transition metals. 
The gold(I) and gold(III) complexes were also applied as pre-
catalysts for several gold-catalyzed transformations. Promising 
activities were found; however as the isothiourea ligands used 
were based on those developed as organocatalysts, rational 
modulation of ligand design will undoubtedly lead to further 
improvements in the future. Finally, these complexes also 
showed promising biological activity towards specific cancer cell 
lines (MCF-7 and HeLa) and for the inhibition of clinically-
important enzymes (-glucuronidase and phosphodiesterase). 
Elaboration of these preliminary studies is currently underway to 
identify mechanisms of action, which will inform future work to 
develop more highly active and selective complexes.[45] 
Experimental Section 
Detailed experimental procedures, characterization data, spectra and X-
ray crystallographic methods and data are available in the supporting 
information. 
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